This substitution is predicted to impair or abolish neurofibromin synthesis, consistent with the severe clinical manifestations observed in the three unrelated patients, who presented with large, moderate, and small plexiform neurofibromas of the pelvis, pancreas, and chest, respectively. This evidence concerns the gene NF1 and plexiform neurofibroma.